Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Clinitech LaboratoryBOM:544220 -7.50%38 Gross Margin % is 76.73% as of Mar. 2026, which is 2% above its 10-year median of 75.30. GuruFocus rates BOM:544220 with a GF Score™ of 38/100. The stock has 6 warning signs investors should review. Among 194 Medical Diagnostics & Research companies, Clinitech Laboratory ranks better than 78.35% on this metric.
The historical rank and industry rank for Clinitech Laboratory's Gross Margin % or its related term are showing as below:
BOM:544220'
s Gross Margin % Range Over the Past 10 Years
Min: 71.67 Med: 75.3 Max: 79.14
Current: 72.84
During the past 6 years, the highestGross Margin % of Clinitech Laboratory was 79.14%. The lowest was 71.67%. And the median was 75.30%.
BOM:544220's Gross Margin % is ranked better than 78.35% of 194
companies
in the Medical Diagnostics & Research industry
Industry Median: 50.825
vs BOM:544220: 72.84
Clinitech Laboratory had a gross margin of 76.73% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Clinitech Laboratory was 1.00% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Clinitech Laboratory had a gross margin of 76.73% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Clinitech Laboratory Gross Margin % Related Terms
Clinitech Laboratory Gross Margin % Historical Data
* Premium members only.
The historical data trend for Clinitech Laboratory's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:544220 vs TMO, DHR, IDXX: Gross Margin % Comparison
For the Diagnostics & Research subindustry, Clinitech Laboratory's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Clinitech Laboratory Gross Margin % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Clinitech Laboratory's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Clinitech Laboratory's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Clinitech Laboratory (BOM:544220) has a Gross Margin % of 76.73% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Clinitech Laboratory and its competitors. This is near median its historical median of 75.30. Over the past decade, Clinitech Laboratory's Gross Margin % has ranged from 71.67 to 79.14. According to the industry distribution chart, Clinitech Laboratory ranks #42 out of 194 companies in the Medical Diagnostics & Research industry, placing it in the top 21.6%.
Is Clinitech Laboratory's Gross Margin % too high?
Clinitech Laboratory's current Gross Margin % of 76.73% is near median its 10-year median of 75.30. Over the past 10 years, this metric has ranged from a low of 71.67 to a high of 79.14. The Medical Diagnostics & Research industry median Gross Margin % is 50.83. Clinitech Laboratory's value of 76.73% is 51% above this industry median. Based on the distribution chart, Clinitech Laboratory ranks #42 out of 194 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Clinitech Laboratory has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Clinitech Laboratory's Gross Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Clinitech Laboratory ranks #42 out of 194 companies for Gross Margin %. This places Clinitech Laboratory in the top 22% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 50.83. Clinitech Laboratory's value of 76.73% is 51% above this benchmark. Historically, Clinitech Laboratory's own Gross Margin % has ranged from 71.67 to 79.14 over the past decade. While the company's 10-year median is 75.30 vs. the industry median of 50.83, Clinitech Laboratory has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Diagnostics & Research company?
The median Gross Margin % among Medical Diagnostics & Research companies is 50.83, based on 194 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Clinitech Laboratory's current Gross Margin % of 76.73% is 51% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Clinitech Laboratory and its competitors. For the Medical Diagnostics & Research industry, the median Gross Margin % is 50.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Clinitech Laboratory's current Gross Margin % is 76.73%, which is near median its own 10-year median of 75.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Clinitech Laboratory stock overvalued right now?
Clinitech Laboratory (BOM:544220) has a current Gross Margin % of 76.73%. The current Gross Margin % is 76.73%, which is near median its 10-year median of 75.30 and 51% above the Medical Diagnostics & Research industry median of 50.83. Clinitech Laboratory's overall GF Score™ is 38/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Clinitech Laboratory (BOM:544220), the current Gross Margin % is 76.73% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Clinitech Laboratory Ltd is an Indian diagnostic and healthcare services provider company. It operates a network of diagnostic centers in Thane and Navi Mumbai and offers various medical tests across multiple specialties, including biochemistry, immunology, hematology, molecular biology, serology, microbiology, and histopathology. It serves individual patients as well as corporate clients, aiming to provide affordable and comprehensive diagnostic solutions.
38GF Score
Get the complete analysis for BOM:544220
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:544220 has been successfully added to your 
